Tim Spelman

Enhanced case detection for newly acquired hepatitis C infection: epidemiological findings and health service implications.

Enhancement of human immunodeficiency virus type 1 replication is not intrinsic to all polyanion-based microbicides.

Surveillance of drug use among young people attending a music festival in Australia, 2005-2008.

Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohort.

HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing.

Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.

Determining the impact of text messaging for sexual health promotion to young people.

Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.

Impact evaluation of a youth sexually transmissible infection awareness campaign using routinely collected data sources.

Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.

Medication chart intervention improves inpatient thromboembolism prophylaxis.

Risk factors for HIV seroconversion in men who have sex with men in Victoria, Australia: results from a sentinel surveillance system.

Sexual history taking and sexually transmissible infection screening practices among men who have sex with men: a survey of Victorian general practitioners.

Intrahousehold transmission of pandemic (H1N1) 2009 virus, Victoria, Australia.

SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans.

Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.

Bronchiectasis is associated with human T-lymphotropic virus 1 infection in an Indigenous Australian population.

Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-saharan Africa.

Wind-driven roof turbines: a novel way to improve ventilation for TB infection control in health facilities.

Prevalence survey of dermatological conditions in mountainous north India.

Splenectomy sequelae: an analysis of infectious outcomes among adults in Victoria.

An automated CPR device compared with standard chest compressions for out-of-hospital resuscitation.

Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individuals.

Self-discharge by adult Aboriginal patients at Alice Springs Hospital, Central Australia: insights from a prospective cohort study.

Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings.

Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.

Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.

The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform.

Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy.

Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome.

Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settings.

Predictors of raised viral load during antiretroviral therapy in patients with and without prior antiretroviral use: a cross-sectional study.

Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry.

High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.

Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individuals.

Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population.

Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy.

Staphylococcus aureus bloodstream infection in Australian hospitals: findings from a Victorian surveillance system.

Lytic gene expression is frequent in HSV-1 latent infection and correlates with the engagement of a cell-intrinsic transcriptional response.

A major reduction in hospital-onset Staphylococcus aureus bacteremia in Australia: a question of definition.

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.

Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B.

C-reactive protein as a predictor of cardiovascular risk in HIV-infected individuals.

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.

Immediate recall of health issues discussed during a pre-travel consultation.

The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals.

Time of Day and Day of Week Trends in EMS Demand.

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis.

Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous australians: results of a case-control study.

Diminishing surgical site infections in Australia: time trends in infection rates, pathogens and antimicrobial resistance using a comprehensive Victorian surveillance program, 2002-2013.

"Seek, Test, Treat" Lessons From Australia: A Study of HIV Testing Patterns From a Cohort of Men Who Have Sex With Men.

Factors associated with discussion of sexual activity and contraception in women with HIV.

Predictors of disability worsening in clinically isolated syndrome.

Central line-associated bloodstream infections in Australian intensive care units: Time-trends in infection rates, etiology, and antimicrobial resistance using a comprehensive Victorian surveillance program, 2009-2013.

Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy.

Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.

Defining reliable disability outcomes in multiple sclerosis.

Which factors influence the activity levels of individuals with traumatic brain injury when they are first discharged home from hospital?

Response to Letter.

Predictors and rate of adjuvant radiation therapy following radical prostatectomy: A report from the Prostate Cancer Registry.

Comparison of oncological and health related quality of life (HRQOL) outcomes between open (ORP) and robotic-assisted radical prostatectomy (RARP) for localized prostate cancer - findings from the population-based Victorian Prostate Cancer Registry (PCR).

2015 - a seminal year for HIV biomedical prevention.